Arthritis, Psoriatic
Information
- Disease name
- Arthritis, Psoriatic
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03942783 | Active, not recruiting | N/A | WORKWELL: Testing Work Advice for People With Arthritis | March 22, 2019 | December 31, 2024 |
| NCT05071664 | Active, not recruiting | Phase 2 | A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis | October 25, 2021 | August 13, 2024 |
| NCT05049798 | Active, not recruiting | A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice | August 25, 2021 | December 7, 2027 | |
| NCT00001291 | Completed | Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions | December 1991 | January 2001 | |
| NCT00126724 | Completed | Phase 1/Phase 2 | Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects | August 2005 | May 2009 |
| NCT00161655 | Completed | Phase 4 | Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis | April 2005 | December 2006 |
| NCT00195377 | Completed | Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain | April 2003 | April 2006 | |
| NCT00265096 | Completed | Phase 3 | A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis | December 2005 | January 2012 |
| NCT05640245 | Completed | Phase 2 | Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis | December 13, 2022 | January 15, 2024 |
| NCT00293709 | Completed | Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists | January 2006 | February 2013 | |
| NCT00293722 | Completed | Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists | January 2006 | February 2013 | |
| NCT00367237 | Completed | Phase 3 | Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422) | May 2006 | March 2008 |
| NCT00683384 | Completed | Study Evaluating the Safety of Enbrel (Etanercept) | January 2007 | October 2009 | |
| NCT00725296 | Completed | Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264) | December 2004 | July 2010 | |
| NCT00727298 | Completed | Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) | February 2006 | August 2011 | |
| NCT00741793 | Completed | Biologic Treatment Registry Across Canada | February 12, 2002 | June 29, 2018 | |
| NCT00760669 | Completed | An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants | May 2007 | April 2011 | |
| NCT00938015 | Completed | Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis | October 2004 | April 2012 | |
| NCT00998829 | Completed | Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis | May 2010 | May 2012 | |
| NCT01009086 | Completed | Phase 3 | A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis | December 2009 | May 2013 |
| NCT01077362 | Completed | Phase 3 | A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents | March 2010 | November 2012 |
| NCT01081717 | Completed | Golimumab Safety and Surveillance Program Using the Ingenix NHI Database | April 14, 2009 | May 31, 2015 | |
| NCT01087788 | Completed | Phase 3 | Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis | March 2010 | August 2015 |
| NCT01199809 | Completed | Phase 1 | A Study of RO5310074 in Patients With Psoriatic Arthritis | February 2011 | February 2012 |
| NCT01313858 | Completed | A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554) | April 2010 | September 2015 | |
| NCT01490450 | Completed | Phase 2 | Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy | December 2011 | June 2015 |
| NCT01976364 | Completed | Phase 3 | Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis | February 17, 2014 | May 20, 2019 |
| NCT02098694 | Completed | N/A | Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis | June 2014 | April 2015 |
| NCT02181673 | Completed | Phase 3 | A Study of Golimumab in Participants With Active Psoriatic Arthritis | September 8, 2014 | March 22, 2017 |
| NCT02294227 | Completed | Phase 3 | 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis | May 29, 2015 | December 19, 2017 |
| NCT02402894 | Completed | Follow-up of Person-centered Care of Young Adults With Rheumatic Disease | February 2015 | December 2022 | |
| NCT02436785 | Completed | N/A | Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening? | May 6, 2015 | January 31, 2018 |
| NCT02714322 | Completed | Phase 3 | MYL-1401A Efficacy and Safety Comparability Study to Humira® | June 2015 | March 2017 |
| NCT02719171 | Completed | Phase 2 | BI 655066/ABBV-066/Risankizumab Compared to Placebo in Patients With Active Psoriatic Arthritis | April 2016 | August 2017 |
| NCT02875184 | Completed | A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands | March 6, 2017 | June 30, 2022 | |
| NCT02886689 | Completed | C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France | January 2007 | December 2011 | |
| NCT02912221 | Completed | N/A | Stepping Up For Inflammatory Arthritis | April 24, 2017 | November 24, 2019 |
| NCT03008590 | Completed | Phase 2 | Low Dose Naltrexone for Chronic Pain From Arthritis | May 1, 2018 | December 31, 2019 |
| NCT03096990 | Completed | A Study of the Real-life Management of Psoriatic Arthritis Patients Treated With Otezla® (Apremilast) in Belgium | April 21, 2017 | December 27, 2018 | |
| NCT03106051 | Completed | Study of Apremilast Use in Patients With Psoriatic Arthritic in Practice Conditions | February 18, 2016 | August 12, 2020 | |
| NCT03142503 | Completed | N/A | The DIET Trial - Dietetic Intervention in Psoriatic Arthritis | January 21, 2013 | June 22, 2015 |
| NCT03158285 | Completed | Phase 3 | A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis | July 12, 2017 | November 10, 2020 |
| NCT03162796 | Completed | Phase 3 | A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s) | August 24, 2017 | November 18, 2019 |
| NCT05000086 | Completed | Phase 4 | A Pilot Study of Technetium [99Tc] Methylene Diphosphonate in the Treatment of Psoriatic Arthritis | June 1, 2019 | July 1, 2021 |
| NCT04173039 | Completed | N/A | Anti-Carbamylated Protein Antibodies in Psoriatic Arthritis | August 29, 2018 | April 24, 2019 |
| NCT03608657 | Completed | Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE) | July 31, 2018 | March 30, 2022 | |
| NCT03747939 | Completed | Phase 4 | Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. | December 31, 2018 | July 5, 2023 |
| NCT00001422 | Completed | Phase 2 | A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis | June 1995 | April 2000 |
| NCT00051623 | Completed | Phase 3 | A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis | May 2003 | June 2004 |
| NCT03796858 | Completed | Phase 3 | A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy | March 22, 2019 | November 11, 2020 |
| NCT03662919 | Completed | One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study | July 2, 2018 | June 30, 2022 | |
| NCT03828045 | Completed | A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment | February 6, 2019 | October 20, 2021 | |
| NCT03733925 | Completed | Phase 4 | A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis | January 7, 2019 | November 15, 2021 |
| NCT06077890 | Not yet recruiting | N/A | Effectiveness of Digital Rehabilitation (SIMPLI.REHAB) in Hand Arthritis | July 2024 | December 2024 |
| NCT06259890 | Recruiting | N/A | Influence of Sodium Intake in spondyLoarthriTes | January 30, 2024 | May 2027 |
| NCT04731831 | Recruiting | Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response. | August 1, 2020 | June 30, 2024 | |
| NCT04821206 | Recruiting | PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors | March 1, 2021 | July 1, 2024 | |
| NCT04882098 | Recruiting | Phase 3 | A Study of Guselkumab in Participants With Active Psoriatic Arthritis | June 17, 2021 | December 8, 2027 |
| NCT04929210 | Recruiting | Phase 4 | A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease | August 30, 2021 | February 13, 2026 |
| NCT04936308 | Recruiting | Phase 3 | Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent | September 28, 2021 | September 7, 2026 |
| NCT05092269 | Recruiting | Phase 3 | A Long-term Extension Study of Ustekinumab in Pediatric Participants | October 18, 2021 | September 29, 2027 |
| NCT05571696 | Recruiting | N/A | Mind Matters: A High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients With Psoriatic Diseases | October 27, 2022 | September 30, 2024 |
| NCT05657847 | Recruiting | Novel Complex Radiodiagnostics of Peripherial Arthropathies | March 7, 2022 | February 1, 2027 | |
| NCT05883371 | Recruiting | IMPACT - AndHealth Autoimmune Research Registry | June 8, 2023 | May 22, 2028 | |
| NCT03703934 | Suspended | Central Pain Mechanisms in Patients With Hand-Osteoarthritis, Psoriatic Arthritis and Healthy Controls | October 20, 2018 | July 30, 2021 | |
| NCT00273858 | Terminated | Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis | March 2006 | July 2010 | |
| NCT00787137 | Terminated | Phase 1 | Single Dose PG102 in Patients With Active Psoriatic Arthritis | December 2008 | May 2010 |
| NCT05083078 | Terminated | Phase 1 | A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritis | November 4, 2021 | July 1, 2022 |
| NCT00239720 | Terminated | Phase 2 | PsA Treatment With hOKT3γ1 (Ala-Ala) | March 16, 2006 | June 25, 2008 |
| NCT00090129 | Terminated | Phase 3 | Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis | September 2004 | June 2005 |
| NCT03565042 | Unknown status | Mechanism of Action of Ustekinumab in Psoriatic Arthritis | December 8, 2015 | November 2018 | |
| NCT03330769 | Unknown status | Ultrasound in Psoriatic Arthritis Treatment | February 3, 2017 | February 29, 2020 | |
| NCT03452735 | Unknown status | Fertility Study of Women With Chronic Inflammatory Rheumatism | July 16, 2018 | July 2019 | |
| NCT04680676 | Withdrawn | Phase 2 | A Study to Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic Arthritis | May 2, 2022 | September 25, 2023 |
| NCT03625089 | Withdrawn | N/A | Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With Arthritis | September 1, 2018 | September 30, 2020 |
| NCT04115020 | Withdrawn | Phase 2 | Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory Arthritis | January 2020 | January 7, 2020 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015535